Bicycle Therapeutics plc (BCYC)
NASDAQ·Healthcare·Biotechnology
$4.68
-1.89%
Mkt Cap $372.77M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 17, 2026 | $7.04M | $47.95M | +581.57% | -$0.94 | -$0.29 | +69.06% | — | — |
| Q4 2025 Oct 30, 2025 | $7.08M | $11.73M | +65.83% | -$1.09 | -$0.85 | +22.02% | — | — |
| Q3 2025 Aug 8, 2025 | $8.38M | $2.92M | -65.16% | -$0.95 | -$1.14 | -20.00% | — | — |
| Q2 2025 May 1, 2025 | $9.24M | $9.98M | +8.01% | -$0.86 | -$0.88 | -2.33% | — | — |
| Q1 2025 Feb 25, 2025 | $7.26M | $3.71M | -48.94% | -$0.85 | -$0.80 | +5.88% | — | — |
| Q4 2024 Oct 31, 2024 | $6.20M | $2.68M | -56.87% | -$0.78 | -$0.74 | +5.13% | — | — |
| Q3 2024 Aug 6, 2024 | $6.17M | $9.37M | +51.89% | -$1.10 | -$0.77 | +30.00% | — | — |
| Q2 2024 May 2, 2024 | $6.03M | $19.52M | +223.70% | -$1.26 | -$0.62 | +50.79% | — | — |
| Q1 2024 Feb 20, 2024 | $7.14M | $5.33M | -25.34% | -$1.23 | -$1.16 | +5.69% | — | — |
| Q4 2023 Nov 2, 2023 | $6.64M | $5.35M | -19.40% | -$1.06 | -$1.26 | -18.87% | — | — |
| Q3 2023 Aug 3, 2023 | $4.58M | $11.40M | +148.84% | -$1.10 | -$1.41 | -28.18% | — | — |
| Q2 2023 May 4, 2023 | $3.88M | $4.90M | +26.19% | -$1.06 | -$1.30 | -22.64% | — | — |
| Q1 2023 Feb 28, 2023 | $3.55M | $3.19M | -10.35% | -$1.06 | -$1.01 | +4.72% | — | — |
| Q4 2022 Nov 3, 2022 | $5.70M | $3.04M | -46.70% | -$0.98 | -$0.96 | +2.04% | — | — |
| Q3 2022 Aug 4, 2022 | $3.69M | $4.38M | +18.70% | -$0.82 | -$0.90 | -9.76% | — | — |
| Q2 2022 May 5, 2022 | $4.46M | $3.86M | -13.54% | -$0.70 | -$0.93 | -32.86% | — | — |
| Q1 2022 Mar 1, 2022 | $5.52M | $3.77M | -31.73% | -$0.60 | -$0.63 | -5.00% | — | — |
| Q4 2021 Nov 4, 2021 | $4.61M | $4.33M | -6.01% | -$0.67 | -$0.59 | +11.94% | — | — |
| Q3 2021 Aug 5, 2021 | $2.31M | $1.78M | -22.73% | -$0.72 | -$0.74 | -2.78% | — | — |
| Q2 2021 May 6, 2021 | $1.76M | $1.81M | +2.90% | -$0.66 | -$0.73 | -10.61% | — | — |